SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-22-000024
Filing Date
2022-02-11
Accepted
2022-02-11 07:00:45
Documents
47
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q siox-20211231.htm   iXBRL 10-Q 1306165
2 EX-31.1 a12312110qsioxexhibit311.htm EX-31.1 11017
3 EX-32.1 a12312110qsioxexhibit321.htm EX-32.1 7127
  Complete submission text file 0001636050-22-000024.txt   4149177

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20211231.xsd EX-101.SCH 26043
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20211231_cal.xml EX-101.CAL 38671
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20211231_def.xml EX-101.DEF 112734
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20211231_lab.xml EX-101.LAB 356887
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20211231_pre.xml EX-101.PRE 213013
41 EXTRACTED XBRL INSTANCE DOCUMENT siox-20211231_htm.xml XML 449788
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 22616655
SIC: 2834 Pharmaceutical Preparations